Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bailey Gregory. Insider active across 3 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 26 filings have been logged. Breakdown: 21 buys · 0 sell. Total volume traded: €14.5m. Activity tracked since 19 August 2022. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bailey Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,583,658 shares@ US$148.5098.6% of flowCommon SharesSEC:0001562180-22-006953:0
25 of 26 declarations
About Bailey Gregory
Bailey Gregory is a declarant and Director of Serina Therapeutics, Inc., Biohaven Ltd., and Biohaven Pharmaceutical Holding Co Ltd. He has 26 filings in total, and across the 26 sampled filings, purchases amount to EUR 14,467,672 and sales to EUR 390,226,335, with activity ranging from 2022-08-22 to 2026-06-22. The modal transaction nature is Acquisition.